Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic Malignancies

Anders Österborg, Yvonne Brandberg, Genadi Iosava, Abdulkadyrov Km, Michael Hedenus, Diethelm Messinger

Journal of Clinical Oncology · 2002 · 309 citations · 26 references

Abstract

Many severely anemic and transfusion-dependent patients with advanced MM, NHL, and CLL and a low performance status benefited from epoetin therapy, with elimination of severe anemia and transfusion need, and improvement in QOL.

References

26